GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Idexx Laboratories, Inc. (IDXX) [hlAlert]

Rating:
Mkt Underperform
IDXX
down 66.00 %

Idexx Laboratories, Inc. (IDXX) downgraded to Mkt Underperform with price target $42 by Avondale

Posted on: Monday,  Feb 1, 2010  12:25 PM ET by Avondale

Avondale rated Mkt Underperform Idexx Laboratories, Inc. (NASDAQ: IDXX) on 02/01/2010, when the stock price was $24.96.
Since then, Idexx Laboratories, Inc. has gained 194.15% as of 01/27/2016's recent price of $73.42.
If you would have followed this Avondale's recommendation on IDXX, you would have lost 66% of your investment in 2186 days.

IDEXX Laboratories, Inc. is a world leader in providing diagnostic, detection, and information products to the animal health industry as well as quality assurance products and services to the food and water industries.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as Forbes.com’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/1/2010 12:25 PM Sell
None
24.96 21.00
as of 12/31/2010
1 Week up  1.14 %
1 Month down  -9.34 %
3 Months down  -13.75 %
1 YTD down  -40.64 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/15/2009 11:25 AM Hold
None
22.66
10/15/2008 12:25 PM Buy
None
20.86 27.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy